Desktop Site |
03 Jan 25 | 16:00 | Close
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 79,223.11 -720.60 -0.90 %
Corporate Announcement
  • Security Code532296
    CompanyGLENMARK PHARMACEUTICALS LTD.
    Exchange Received Time10/12/2024 06:55:31
    Exchange Disseminated Time10/12/2024 06:55:32
    Time Taken00:00:01
     
     
     Announcement under Regulation 30 (LODR)-Press Release / Media Release | 12/10/24 06:55 
     Ichnos Glenmark Innovation (IGI) presents first clinical data from phase 1 study of Trisoecific TREAT Antibody, ISB 2001, showing high overall response rate (ORR) with durable responses and favourable safety profile in patients with heavily pretreated Multiple Myeloma 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(42) 06 Jan 25|07:51 (IST)